SAL-0951 in the Treatment of Chemotherapy-induced Anemia in Patients With Non-myeloid Malignancies

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2025
The purpose of this study is to evaluate the safety and efficacy of SAL-0951 in the treatment of chemotherapy-induced anemia (CIA) in patients with non-myeloid malignancies
Epistemonikos ID: 3f4eb2001d4e56d2101d7b5abbddc42ade258de9
First added on: Jan 01, 2025